Simplify Logo
WCG Clinical

WCG Clinical

Clinical trial management services and technologies

Associate Compliance & QA - Technology

Full-TimeDeadline 8/31/27
$52.5k - $81.5k/yr
Mid
Bachelor's
Remote in USA
Remote

Remote within the United States; occasional travel of 5%–10% is required.

About the job

Requirements
  • A bachelor's degree in a scientific, technical, or related field, or an equivalent combination of education, skills, and experience.
  • Two to four years of experience in a quality or regulatory compliance position supporting and contributing to quality assurance projects or assignments.
  • Knowledge of current Food and Drug Administration and International Council for Harmonisation Good Clinical Practice guidelines as they apply to clinical studies.
  • Experience supporting customer or sponsor audits of organizational processes, training, and documentation.
  • Knowledge of 21 CFR Part 11 scope and application and computerized system validation processes.
  • Experience executing and documenting computerized system validation efforts for systems used in clinical trials.
  • Experience delivering training materials related to company standards and regulatory requirements.
  • Ability to contribute to and execute workstreams within multi-departmental projects.
  • Effective written and oral communication, organization, and interpersonal skills, with the ability to interact with staff, sponsors, and regulatory agencies as needed.
  • Demonstrated technical writing skills.
  • Ability to problem solve and engage in conflict resolution.
  • Ability to multitask and work efficiently and independently.
Responsibilities
  • Support the continued development, maintenance, and enforcement of the WCG Quality Management System and quality department standards.
  • Support maintenance of WCG quality goals, objectives, and process improvements.
  • Educate WCG staff on quality department standards and best practices.
  • Work with WCG staff to author and revise internal technology standards, including information technology and software development policies and standard operating procedures.
  • Support the development, validation, implementation, and change management of systems in accordance with regulatory agency regulations and guidance, including GxP, 21 CFR Part 11 and Annex 11, GDPR, and HIPAA.
  • Develop and review validation deliverables related to the implementation or development of WCG systems.
  • Support investigations of Quality Events, Corrective Actions and Preventive Actions, deviations, and notes to file, and execute assigned compliance tasks within defined timelines.
  • Conduct internal audits to verify compliance with WCG processes, regulatory requirements, guidance, and staff performance standards.
  • Conduct external vendor qualification audits to verify vendor standards and performance.
  • Support external audits through preparation activities, audit report review, and finding resolution.
  • Maintain current knowledge of quality legislation and regulatory compliance best practices.
  • Perform other duties assigned by the supervisor.

About the company

WCG Clinical provides services and technologies to streamline clinical research for pharmaceutical companies, research organizations, and institutions. It covers ethical review, site administration, patient recruitment, quality management, and training, built through acquisitions like PharmaSeek, The Avoca Group, MedAvante, and Array to cover the full trial workflow. It differentiates itself by offering a consolidated ecosystem with a broad set of capabilities across the trial lifecycle. Its goal is to reduce time and cost to bring new medical treatments to market by improving the efficiency and effectiveness of clinical research.

Company Size

501-1,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Princeton, New Jersey

Founded

1968

Get referred to WCG Clinical

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • WCG launched Trial IntelX in January 2026; Syneos Health adopted it first.
  • WCG agreed April 2026 to buy The Contract Network for study-startup automation.
  • Anthony Doyle joined as CFO June 15, 2026, strengthening operating discipline.

What critics are saying

  • Clario's March 2025 eCOA acquisition strips WCG of a specialized revenue stream.
  • Trifecta's Delaware lawsuit survived dismissal in June 2024, pressuring payouts and management time.
  • Trial IntelX must win customers in 2026 or integrated CROs commoditize WCG's software layer.

What makes WCG Clinical unique

  • WCG ClinSphere unifies ethics, feasibility, contracts, imaging, and training across trial startup.
  • Trial IntelX benchmarks 80,000 protocols and 40,000 trials for predictive design.
  • WCG combines oversight services with AI workflow tools, unlike point-solution vendors.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Company Match

Health Savings Account/Flexible Spending Account

Employee Referral Bonus

Tuition Reimbursement

Training Programs

Professional Certification Support

Continuing Education Support

Paid Holidays

Paid Vacation

Paid Sick Leave

Company News

GlobeNewswire
Aug 21st, 2026
Avance Clinical appoints inaugural Chief Commercial Officer, reinforcing global growth strategy.

Avance Clinical appoints inaugural Chief Commercial Officer, reinforcing global growth strategy. ADELAIDE, Australia, Aug. 21, 2026 (GLOBE NEWSWIRE) - Avance Clinical, a global full-service CRO headquartered in Australia dedicated to servicing international biotechs, today announced the appointment of Tim Schuckman as its first Chief Commercial Officer (CCO). Schuckman joined the company on Monday 17 August in a newly created executive role that reflects Avance Clinical's continued growth, deeper client partnerships, and expanding presence across North America, Asia, and Europe. "Tim's arrival comes at a pivotal moment for Avance Clinical," said Mark Harvill, CEO of Avance Clinical. The creation of the CCO role gives Avance Clinical dedicated executive leadership across commercial strategy, business development, proposals, client engagement, market expansion and strategic partnerships, as the company sharpens its focus to meet accelerating demand from biotech sponsors worldwide. Schuckman brings more than a decade of senior commercial leadership from WCG Clinical, a leading provider of clinical research solutions, where he held progressively senior commercial roles before serving as Chief Commercial Officer. Based outside of Cincinnati, Ohio, Schuckman holds a Bachelor of Arts in Business Management and Marketing from Wittenberg University. During Schuckman's tenure at WCG, he built and mentored commercial teams of more than 50 people, delivered double-digit year-over-year net bookings growth, and led enterprise-wide commercial transformation initiatives, including facilitating the integration of more than 30 acquisitions to strengthen client capability. His experience developing commercial strategy, strengthening client partnerships and building high-performing teams positions him well to support Avance Clinical's next phase of growth. "I'm excited to join Avance Clinical at such a significant point in its growth," said Schuckman. "The company has built a genuinely differentiated position for biotech sponsors globally, and I look forward to partnering across the business to sharpen our commercial focus, strengthen client relationships and support Avance Clinical's continued expansion into new markets." Reporting directly to CEO Mark Harvill and joining the Executive Leadership Team, Schuckman will lead Avance Clinical's commercial functions, partnering closely across the business to ensure priorities remain aligned with operational capability and client needs. "Tim's arrival comes at a pivotal moment for Avance Clinical," said Mark Harvill, CEO of Avance Clinical. "As we continue to expand our services in the Australia/New Zealand region and build our global presence to support the biotech sponsors we serve, it is the right time to establish dedicated executive leadership focused on our commercial strategy. Tim's track record of building high-performing teams and delivering sustained growth in clinical research services makes him the right person to help lead the next chapter of our story. I am delighted to welcome him to our team." About Avance Clinical Avance Clinical is a full-service, Australian-headquartered global Contract Research Organization, servicing international biotechs across North America, Europe, Asia Pacific and China. Specializing in early-phase and First-in-Human studies across more than 250 indications, as well as Oncology, Renal, Metabolic, and Central Nervous System trials, Avance Clinical has partnered with more than 700 emerging biotech companies to accelerate their programs to critical development milestones. Avance Clinical is the 2026 Frost & Sullivan Global Company of the Year in the Biotech CRO industry. To learn more, visit www.avancecro.com. Find out more: For media enquiries, email [email protected].

PR Newswire
Jun 11th, 2026
WCG names Anthony Doyle as CFO to drive growth and operational scale

WCG, a global clinical research solutions provider, has appointed Anthony Doyle as chief financial officer, effective 15 June 2026. He succeeds Robert VanHees, who will remain as special adviser until 31 December 2026. Doyle brings over 20 years of financial leadership experience in healthcare and clinical research. He joins from Flourish Research, where he serves as CFO. Previously, he held CFO roles at BioCryst Pharmaceuticals and Worldwide Clinical Trials, leading organisations through growth and operational transformation. He also held finance leadership positions at General Electric. CEO Sam Srivastava said Doyle's financial expertise and industry experience align with WCG's strategic direction as the company expands capabilities across the clinical research ecosystem. Doyle expressed enthusiasm about supporting WCG's continued growth and strategic investment.

PR Newswire
Apr 21st, 2026
WCG acquires The Contract Network to extend AI-driven site enablement across clinical trial study start-up

WCG, a global clinical research solutions provider, has announced an agreement to acquire The Contract Network, extending its ClinSphere AI platform's capabilities across study start-up and contract management. Financial terms were not disclosed. The Contract Network specialises in applying AI to contract and study start-up workflows, technology co-developed with academic medical centres including Mayo Clinic. The acquisition will integrate these capabilities into WCG's existing AI-powered ecosystem, which includes Trial IntelX for predictive trial design and site feasibility. The combined platform aims to identify contract and budget misalignments at document creation, before they cause delays. WCG says the integration will create the industry's most comprehensive AI-enabled platform for clinical research operations, spanning trial design, site selection, ethical review and contract intelligence.

PR Newswire
Jun 11th, 2025
Wcg Centerwatch Celebrates Excellence In Clinical Trial Collaborations With Inaugural Pinnacle Award For Site Relationships

CARY, N.C., June 11, 2025 /PRNewswire/ -- WCG, a global leader in providing solutions that measurably improve and accelerate clinical research, proudly announces the winners of the first-ever prestigious WCG Pinnacle Award, Site Relationships. Award winners were chosen based on the results of WCG's 2025 CenterWatch Global Site Relationship Survey that captured insights from more than 12,000 respondents, including more than 19,000 ratings for sponsors and nearly 10,000 ratings for CROs, highlighting 40 key attributes such as communication quality, professionalism, technology use, and efficient site management.Designed to honor exemplary performance in fostering strong relationships between clinical trial sponsors or contract research organizations (CROs) and investigational sites, this accolade emphasizes the dedication to enhancing collaboration, protocol excellence, site operations, participant diversity, and technology management required to advance clinical research for the betterment of medical science and patient care. WCG Pinnacle Award recipients represent the top performers based upon customer satisfaction (CSAT) scores across a variety of attributes.2025 WCG Pinnacle Award, Site Relationship winners include:Bayer – Overall Site Relationship LeaderNovo Nordisk – Overall Site Relationship LeaderIQVIA – Leadership in Professionalism and CommunicationMedpace – Leadership in Professionalism and CommunicationParexel – Leadership in TechnologyThe 2025 award winners have demonstrated exceptional commitment to advancing clinical research through strong site relationships, reinforcing their status as industry leaders and role models."We are honored to recognize organizations like Bayer, Novo Nordisk, IQVIA, Medpace, and Parexel that excel in the vital area of site relationships," said Sam Srivastava, chief executive officer, WCG. "Pinnacle Award recipients exemplify the industry's drive toward innovation and excellence, enhancing clinical trial collaborations. Their dedication inspires continued progress in clinical research throughout the industry.""Strong site relationships are essential for the successful navigation of clinical trials," noted Mette Andersen, general manager, Data & Insights, WCG. "These award-winning organizations have shown that fostering site connections leads to more efficient operations and improved outcomes in clinical research."Since 1997, the WCG CenterWatch Global Site Relationship Survey has served as a valuable tool for sponsors and CROs seeking to benchmark their practices and drive improvements

PR Newswire
Mar 10th, 2025
Clario Enters Into Definitive Agreement To Acquire Wcg'S Ecoa Business

Acquisition of WCG's electronic clinical outcome assessments (eCOA) business will expand Clario's scientific expertise and offerings in neurosciencePHILADELPHIA, March 10, 2025 /PRNewswire/ -- Clario, a leading provider of endpoint data solutions to the clinical trial industry, today announced they have entered into a definitive agreement to acquire the eCOA business of WCG, a leader in providing solutions that measurably improve and accelerate clinical research. Electronic clinical outcomes assessments (eCOA), in addition to paper assessments, are used to evaluate the safety and efficacy of new drugs by measuring how a clinical trial participant feels or functions. WCG's eCOA operations offer robust, full-service clinical expertise and specialized functionality, particularly in neurology, psychiatry, neuropathic pain, and rare diseases